To promote Congressional awareness of the impact of healthcare policies on the research based biopharmaceutical and medical technology industry; monitor legislation related to drug prices and proposals related to tariffs on pharmaceutical products as well as domestic manufacturing
2025 · 3rd Quarter (July 1 - Sep 30)
HEALTHCARE INSTITUTE OF NEW JERSEY
Filed by WINNING STRATEGIES WASHINGTON.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2025
- Income
- $10,000.00
- Expenses
- Not reported
- Registrant
- WINNING STRATEGIES WASHINGTON
- Filing UUID
- 276a22a1-8d98-45d9-8c4a-6d373f55e13d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.